MANNKIND CORP
For the period ended Dec 31, 2024. Filed Feb 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 26, 2025
MNKD$4.19+7.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, 2024 | December 31, 2023 | |
|---|---|---|
| (In thousands except share and per share data) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $46,339 | $238,480 |
| Short-term investments | 150,917 | 56,619 |
| Accounts receivable, net | 11,804 | 14,901 |
| Inventory | 27,886 | 28,545 |
| Prepaid expenses and other current assets | 31,360 | 34,848 |
| Total current assets | 268,306 | 373,393 |
| Restricted cash | 737 | — |
| Long-term investments | 5,482 | 7,155 |
| Property and equipment, net | 85,365 | 84,220 |
| Goodwill | 1,931 | 1,931 |
| Other intangible assets | 5,265 | 1,073 |
| Other assets | 26,757 | 7,426 |
| Total assets | $393,843 | $475,198 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $6,792 | $9,580 |
| Accrued expenses and other current liabilities | 40,293 | 42,036 |
| Liability for sale of future royalties – current | 12,283 | 9,756 |
| Financing liability – current | 10,062 | 9,809 |
| Deferred revenue – current | 12,407 | 9,085 |
| Recognized loss on purchase commitments – current | — | 3,859 |
| Midcap credit facility – current | — | 20,000 |
| Total current liabilities | 81,837 | 104,125 |
| Senior convertible notes | 36,051 | 226,851 |
| Liability for sale of future royalties – long term | 137,362 | 136,054 |
| Financing liability – long term | 93,877 | 94,319 |
| Deferred revenue – long term | 51,160 | 69,794 |
| Recognized loss on purchase commitments – long term | 58,204 | 60,942 |
| Operating lease liability | 11,645 | 3,925 |
| Milestone liabilities | 2,523 | 3,452 |
| Midcap credit facility – long term | — | 13,019 |
| Mann Group convertible note | — | 8,829 |
| Accrued interest – Mann Group convertible note | — | 56 |
| Total liabilities | 472,659 | 721,366 |
| Commitments and contingencies (Note 16) | ||
| Stockholders' deficit: | ||
| Undesignated preferred stock, $0.01 par value – 10,000,000 shares authorized; no shares issued or outstanding as of December 31, 2024 or 2023 | — | — |
| Common stock, $0.01 par value – 800,000,000 shares authorized; 302,959,782 and 270,034,495 shares issued and outstanding as of December 31, 2024 and 2023, respectively | 3,029 | 2,700 |
| Additional paid-in capital | 3,118,865 | 2,980,539 |
| Accumulated other comprehensive income | 1,109 | — |
| Accumulated deficit | (3,201,819) | (3,229,407) |
| Total stockholders' deficit | (78,816) | (246,168) |
| Total liabilities and stockholders' deficit | $393,843 | $475,198 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.